Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,490.00p

Buy

2,200.00p

arrow-down-4.00p (-0.26%)

Prices updated at 18 Dec 2025, 18:31 GMT

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

FTSE All-Share

0.65%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	1,519.00p - 1,498.00p
	2,360.00p - 1,482.00p
	3.13
	3,352.78m
	12.09
	500
	890,819
	1.76
	589,066.42
	1.04
	234.72m
	GB00B0LCW083
	1.67
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.